Your browser doesn't support javascript.
loading
Patient acceptability of, and attitudes towards, hepatitis B cure research - A scoping review and identification of knowledge gaps.
Mohtashemi, Neaka; Dubé, Karine; Thio, Chloe; Song, Sihyeong; Patel, Shail; Sugarman, Jeremy; Bhattacharya, Debika.
Afiliação
  • Mohtashemi N; University of California, Los Angeles, Los Angeles, CA, USA.
  • Dubé K; University of California, San Diego, San Diego, CA, USA.
  • Thio C; Johns Hopkins University, Baltimore, MD, USA.
  • Song S; University of California, Los Angeles, Los Angeles, CA, USA.
  • Patel S; University of California, Los Angeles, Los Angeles, CA, USA.
  • Sugarman J; Johns Hopkins University, Baltimore, MD, USA.
  • Bhattacharya D; University of California, Los Angeles, Los Angeles, CA, USA.
J Virus Erad ; 9(4): 100354, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38161322
ABSTRACT
Functional cure, defined as durable loss of hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA suppression off therapy, is an increasingly important goal in the treatment of chronic hepatitis B. Although novel treatments aimed at achieving functional cure are being developed and tested in clinical trials, it is important to assess the perspectives of people living with HBV towards these potential treatments and their participation in HBV functional cure research. We have performed a scoping review that revealed that there is limited knowledge regarding patient perspectives of HBV functional cure research and then identified gaps in knowledge for further investigation. Our work highlights the need for further studies in patient perspectives in HBV functional cure research.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Systematic_reviews Idioma: En Ano de publicação: 2023 Tipo de documento: Article